Figure 4From: Synthesis of hapten and preparation of specific polyclonal antibody with high affinity for lenalidomide, the potent drug for treatment of multiple myelomaAbsorption spectra of G-LND (50 μg/mL; 1) and equal concentrations (0.5 mg/mL) of BSA (2) and LND-BSA conjugate (3). Concentration of LND-BSA conjugate was determined as BSA protein. Concentrations were prepared in phosphate buffered saline.Back to article page